Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

CD44 promotes the migration of bone marrow-derived mesenchymal stem cells toward glioma.

Yin Q, Zhou YY, Wang P, Ma LI, Li P, Wang XG, She CH, Li WL.

Oncol Lett. 2016 Apr;11(4):2353-2358. Epub 2016 Feb 24.

2.

A glimpse of the ERM proteins.

Ponuwei GA.

J Biomed Sci. 2016 Mar 17;23:35. doi: 10.1186/s12929-016-0246-3. Review.

3.

Hyaluronan Is Crucial for Stem Cell Differentiation into Smooth Muscle Lineage.

Simpson RM, Hong X, Wong MM, Karamariti E, Bhaloo SI, Warren D, Kong W, Hu Y, Xu Q.

Stem Cells. 2016 May;34(5):1225-38. doi: 10.1002/stem.2328. Epub 2016 Mar 4.

4.

Cancer metastases: challenges and opportunities.

Guan X.

Acta Pharm Sin B. 2015 Sep;5(5):402-18. doi: 10.1016/j.apsb.2015.07.005. Epub 2015 Sep 8. Review.

5.

Hyaluronan as a therapeutic target in human diseases.

Liang J, Jiang D, Noble PW.

Adv Drug Deliv Rev. 2016 Feb 1;97:186-203. doi: 10.1016/j.addr.2015.10.017. Epub 2015 Nov 2. Review.

6.

CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination.

Ravindranath AK, Kaur S, Wernyj RP, Kumaran MN, Miletti-Gonzalez KE, Chan R, Lim E, Madura K, Rodriguez-Rodriguez L.

Oncotarget. 2015 Sep 22;6(28):26308-21. doi: 10.18632/oncotarget.4763.

7.

Distinct Intracellular Domain Substrate Modifications Selectively Regulate Ectodomain Cleavage of NRG1 or CD44.

Parra LM, Hartmann M, Schubach S, Li Y, Herrlich P, Herrlich A.

Mol Cell Biol. 2015 Oct;35(19):3381-95. doi: 10.1128/MCB.00500-15. Epub 2015 Jul 27.

8.

Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation.

Guvench O.

Front Immunol. 2015 Jun 16;6:305. doi: 10.3389/fimmu.2015.00305. eCollection 2015. Review.

9.

CD44S-hyaluronan interactions protect cells resulting from EMT against anoikis.

Cieply B, Koontz C, Frisch SM.

Matrix Biol. 2015 Oct;48:55-65. doi: 10.1016/j.matbio.2015.04.010. Epub 2015 Apr 30.

10.

Quantification of HER family receptors in breast cancer.

Nuciforo P, Radosevic-Robin N, Ng T, Scaltriti M.

Breast Cancer Res. 2015 Apr 9;17:53. doi: 10.1186/s13058-015-0561-8. Review.

11.

Diagnostic value of Wilms tumor 1 and CD44 in Langerhans cell sarcoma: case series of 4 patients.

Wang CS, Chen YP, He WH, Yin J, Gao CF, Wang P, Li H, Lv XX.

Medicine (Baltimore). 2015 Apr;94(13):e636. doi: 10.1097/MD.0000000000000636.

12.

Interleukin-1β-induced Reduction of CD44 Ser-325 Phosphorylation in Human Epidermal Keratinocytes Promotes CD44 Homomeric Complexes, Binding to Ezrin, and Extended, Monocyte-adhesive Hyaluronan Coats.

Jokela T, Oikari S, Takabe P, Rilla K, Kärnä R, Tammi M, Tammi R.

J Biol Chem. 2015 May 8;290(19):12379-93. doi: 10.1074/jbc.M114.620864. Epub 2015 Mar 25.

13.

Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma.

Pore D, Bodo J, Danda A, Yan D, Phillips JG, Lindner D, Hill BT, Smith MR, Hsi ED, Gupta N.

Leukemia. 2015 Sep;29(9):1857-67. doi: 10.1038/leu.2015.86. Epub 2015 Mar 24.

14.

Phosphatidylinositol 4,5-bisphosphate clusters the cell adhesion molecule CD44 and assembles a specific CD44-Ezrin heterocomplex, as revealed by small angle neutron scattering.

Chen X, Khajeh JA, Ju JH, Gupta YK, Stanley CB, Do C, Heller WT, Aggarwal AK, Callaway DJ, Bu Z.

J Biol Chem. 2015 Mar 6;290(10):6639-52. doi: 10.1074/jbc.M114.589523. Epub 2015 Jan 8.

15.

Time-domain microfluidic fluorescence lifetime flow cytometry for high-throughput Förster resonance energy transfer screening.

Nedbal J, Visitkul V, Ortiz-Zapater E, Weitsman G, Chana P, Matthews DR, Ng T, Ameer-Beg SM.

Cytometry A. 2015 Feb;87(2):104-18. doi: 10.1002/cyto.a.22616. Epub 2014 Dec 18.

16.

MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.

Wang SH, Zhou JD, He QY, Yin ZQ, Cao K, Luo CQ.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):7131-41. eCollection 2014.

17.

Imaging tumour heterogeneity of the consequences of a PKCα-substrate interaction in breast cancer patients.

Weitsman G, Lawler K, Kelleher MT, Barrett JE, Barber PR, Shamil E, Festy F, Patel G, Fruhwirth GO, Huang L, Tullis ID, Woodman N, Ofo E, Ameer-Beg SM, Irshad S, Condeelis J, Gillett CE, Ellis PA, Vojnovic B, Coolen AC, Ng T.

Biochem Soc Trans. 2014 Dec;42(6):1498-505. doi: 10.1042/BST20140165. Review.

18.

Cytoskeletal regulation of CD44 membrane organization and interactions with E-selectin.

Wang Y, Yago T, Zhang N, Abdisalaam S, Alexandrakis G, Rodgers W, McEver RP.

J Biol Chem. 2014 Dec 19;289(51):35159-71. doi: 10.1074/jbc.M114.600767. Epub 2014 Oct 30.

19.
20.

Emerging roles for hyaluronidase in cancer metastasis and therapy.

McAtee CO, Barycki JJ, Simpson MA.

Adv Cancer Res. 2014;123:1-34. doi: 10.1016/B978-0-12-800092-2.00001-0. Review.

Supplemental Content

Support Center